CHI3L-1 demonstrated prognostic significance for AKI progression and mortality too; in a cohort of 249 AKI patients, urine CHI3L-1 concentrations ≥ 5 ng/mL were associated with disease progression or in-hospital mortality [68]. Here, CHI3L1 is linked to acute kidney injury.